Literature DB >> 11506502

Hyaluronan production increases the malignant properties of mesothelioma cells.

Y Li1, P Heldin.   

Abstract

Malignant pleural mesotheliomas is in most cases associated with elevated amounts of hyaluronan. To investigate the importance of hyaluronan for the malignant properties of mesotheliomas, we have expressed murine hyaluronan synthase 2 (HAS2) in the non-hyaluronan producing mesothelioma cell line, Mero-25. We found that upon hyaluronan overproduction the mesothelioma cells changed their epitheloid character to a fibroblastic phenotype and were surrounded by pericellular matrices, the size of which correlated to the amount of synthesized hyaluronan. HAS2-transfected cells with the ability to synthesize about 520 ng hyaluronan/5 x 10(4)cells/24 h exhibited about a 2-fold increase in the expression of the cell surface hyaluronan receptor CD44 and their locomotion increased compared to that of mock-transfected Mero-25 cells. Furthermore, the malignant properties of mesothelioma cell clones as determined by the ability to grow in a soft agar assay correlated to their hyaluronan production. These results provide evidence for an important role of hyaluronan in the aggressive spread of mesotheliomas in adjacent non-cancerous stromal tissues. Copyright 2001 Cancer Research Campaign.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11506502      PMCID: PMC2364109          DOI: 10.1054/bjoc.2001.1922

Source DB:  PubMed          Journal:  Br J Cancer        ISSN: 0007-0920            Impact factor:   7.640


  44 in total

1.  Expression of recombinant hyaluronan synthase (HAS) isoforms in CHO cells reduces cell migration and cell surface CD44.

Authors:  J Brinck; P Heldin
Journal:  Exp Cell Res       Date:  1999-11-01       Impact factor: 3.905

2.  Cellular tumorigenicity in nude mice: correlation with cell growth in semi-solid medium.

Authors:  V H Freedman; S I Shin
Journal:  Cell       Date:  1974-12       Impact factor: 41.582

3.  On the pericellular zone of some mammalian cells in vitro.

Authors:  B J Clarris; J R Fraser
Journal:  Exp Cell Res       Date:  1968-01       Impact factor: 3.905

4.  Hyaluronan in serum as an indicator of progressive disease in hyaluronan-producing malignant mesothelioma.

Authors:  A Thylén; J Wallin; G Martensson
Journal:  Cancer       Date:  1999-11-15       Impact factor: 6.860

5.  Quantitative analysis of hyaluronate in nanogram amounts.

Authors:  A Tengblad
Journal:  Biochem J       Date:  1980-01-01       Impact factor: 3.857

6.  A longitudinal study of the hyaluronan level in the serum of patients with malignant mesothelioma under treatment. Hyaluronan as an indicator of progressive disease.

Authors:  I M Dahl; O P Solheim; B Erikstein; E Müller
Journal:  Cancer       Date:  1989-07-01       Impact factor: 6.860

7.  Expression of human hyaluronan synthases in response to external stimuli.

Authors:  A Jacobson; J Brinck; M J Briskin; A P Spicer; P Heldin
Journal:  Biochem J       Date:  2000-05-15       Impact factor: 3.857

8.  Irradiation-induced expression of hyaluronan (HA) synthase 2 and hyaluronidase 2 genes in rat lung tissue accompanies active turnover of HA and induction of types I and III collagen gene expression.

Authors:  Y Li; M Rahmanian; C Widström; G Lepperdinger; G I Frost; P Heldin
Journal:  Am J Respir Cell Mol Biol       Date:  2000-09       Impact factor: 6.914

Review 9.  The role of CD44 as a cell surface hyaluronan receptor during tumor invasion of connective tissue.

Authors:  W Knudson
Journal:  Front Biosci       Date:  1998-07-01

10.  Inhibition of leukocyte locomotion by hyaluronic acid.

Authors:  J V Forrester; P C Wilkinson
Journal:  J Cell Sci       Date:  1981-04       Impact factor: 5.285

View more
  34 in total

1.  Inhibition of hyaluronan degradation by dextran sulphate facilitates characterisation of hyaluronan synthesis: an in vitro and in vivo study.

Authors:  Lishanthi Udabage; Gary R Brownlee; Robert Stern; Tracey J Brown
Journal:  Glycoconj J       Date:  2004       Impact factor: 2.916

2.  Chronic UVR causes increased immunostaining of CD44 and accumulation of hyaluronan in mouse epidermis.

Authors:  Hanna Siiskonen; Kari Törrönen; Timo Kumlin; Kirsi Rilla; Markku I Tammi; Raija H Tammi
Journal:  J Histochem Cytochem       Date:  2011-08-10       Impact factor: 2.479

3.  Caution should be used in long-term treatment with oral compounds of hyaluronic acid in patients with a history of cancer.

Authors:  Procopio Simone; Migliore Alberto
Journal:  Clin Drug Investig       Date:  2015-11       Impact factor: 2.859

Review 4.  Cellular and molecular parameters of mesothelioma.

Authors:  Maria E Ramos-Nino; Joseph R Testa; Deborah A Altomare; Harvey I Pass; Michele Carbone; Maurizio Bocchetta; Brooke T Mossman
Journal:  J Cell Biochem       Date:  2006-07-01       Impact factor: 4.429

Review 5.  Hyaluronan in immune dysregulation and autoimmune diseases.

Authors:  Nadine Nagy; Hedwich F Kuipers; Payton L Marshall; Esther Wang; Gernot Kaber; Paul L Bollyky
Journal:  Matrix Biol       Date:  2018-04-04       Impact factor: 11.583

6.  Hyaluronan synthase 2 (HAS2) promotes breast cancer cell invasion by suppression of tissue metalloproteinase inhibitor 1 (TIMP-1).

Authors:  Berit Bernert; Helena Porsch; Paraskevi Heldin
Journal:  J Biol Chem       Date:  2011-10-20       Impact factor: 5.157

Review 7.  Hyaluronan-CD44 interactions as potential targets for cancer therapy.

Authors:  Suniti Misra; Paraskevi Heldin; Vincent C Hascall; Nikos K Karamanos; Spyros S Skandalis; Roger R Markwald; Shibnath Ghatak
Journal:  FEBS J       Date:  2011-03-25       Impact factor: 5.542

Review 8.  Role of Pericellular Matrix in the Regulation of Cancer Stemness.

Authors:  Sofia Avnet; Margherita Cortini
Journal:  Stem Cell Rev Rep       Date:  2016-08       Impact factor: 5.739

9.  Protumorigenic role of HAPLN1 and its IgV domain in malignant pleural mesothelioma.

Authors:  Alla V Ivanova; Chandra M V Goparaju; Sergey V Ivanov; Daisuke Nonaka; Christina Cruz; Amanda Beck; Fulvio Lonardo; Anil Wali; Harvey I Pass
Journal:  Clin Cancer Res       Date:  2009-04-07       Impact factor: 12.531

10.  Sonic hedgehog signaling directly targets Hyaluronic Acid Synthase 2, an essential regulator of phalangeal joint patterning.

Authors:  Jiang Liu; Qiang Li; Michael R Kuehn; Ying Litingtung; Steven A Vokes; Chin Chiang
Journal:  Dev Biol       Date:  2013-01-08       Impact factor: 3.582

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.